Although it is clear that proteins such as MBNL1 are major players in DM1 pathogenesis, we hypothesize that other RBPs such as Stau1 play important functions as disease modifiers, where the fine-tuning of such genes likely contribute together to the disease progression and severity. Here, STAU1 is linked to myotonic dystrophy type 1.